Quantcast

Grand Canyon Times

Thursday, November 21, 2024

Arizona: Biologics companies were the second most FDA inspected companies in Arizona in Q4 2023

Webp 51tcce8qtq0gv3h0ttdr040fsao9

Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website

Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website

In the fourth quarter of 2023, six Biologics companies received seven FDA inspections in Arizona, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in Arizona, equalling 17.1% of all inspections in the fourth quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in Arizona During Q4 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring4----
Blood and Blood Products5----
Compliance: Devices41--
Drug Quality Assurance----2
Foodborne Biological Hazards211--
Human Cellular, Tissue, and Gene Therapies1----
Monitoring of Marketed Animal Drugs, Feed, and Devices2----
Postmarket Assurance: Devices5----
Tobacco Post-Market Activities1----
Unapproved and Misbranded Drugs----1

MORE NEWS